Back to Search Start Over

Decay of Fc-dependent antibody functions after mild to moderate COVID-19.

Authors :
Lee WS
Selva KJ
Davis SK
Wines BD
Reynaldi A
Esterbauer R
Kelly HG
Haycroft ER
Tan HX
Juno JA
Wheatley AK
Hogarth PM
Cromer D
Davenport MP
Chung AW
Kent SJ
Source :
Cell reports. Medicine [Cell Rep Med] 2021 Jun 15; Vol. 2 (6), pp. 100296. Date of Electronic Publication: 2021 May 09.
Publication Year :
2021

Abstract

The capacity of antibodies to engage with immune cells via the Fc region is important in preventing and controlling many infectious diseases. The evolution of such antibodies during convalescence from coronavirus disease 2019 (COVID-19) is largely unknown. We develop assays to measure Fc-dependent antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-expressing cells in serial samples from subjects primarily with mild-moderate COVID-19 up to 149 days post-infection. We find that S-specific antibodies capable of engaging Fcγ receptors decay over time, with S-specific antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent phagocytosis (ADP) activity within plasma declining accordingly. Although there is significant decay in ADCC and ADP activity, they remain readily detectable in almost all subjects at the last time point studied (94%) in contrast with neutralization activity (70%). Although it remains unclear the degree to which Fc effector functions contribute to protection against SARS-CoV-2 re-infection, our results indicate that antibodies with Fc effector functions persist longer than neutralizing antibodies.<br />Competing Interests: The authors declare no competing interests.<br /> (© 2021 The Author(s).)

Details

Language :
English
ISSN :
2666-3791
Volume :
2
Issue :
6
Database :
MEDLINE
Journal :
Cell reports. Medicine
Publication Type :
Academic Journal
Accession number :
33997824
Full Text :
https://doi.org/10.1016/j.xcrm.2021.100296